{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:00:50Z","timestamp":1769306450570,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.nano.2020.102252","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T11:43:48Z","timestamp":1593431028000},"page":"102252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Redox-sensitive polyglutamic acid-platinum(IV) prodrug grafted nanoconjugates for efficient delivery of cisplatin into breast tumor"],"prefix":"10.1016","volume":"29","author":[{"given":"Ruijuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2020.102252_bb0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.nano.2020.102252_bb0010","first-page":"1663","article-title":"Cisplatin and platinum drugs at the molecular level (review)","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nano.2020.102252_bb0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2020.102252_bb0020","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/cr068207j","article-title":"Direct cellular responses to platinum-induced DNA damage","volume":"107","author":"Jung","year":"2007","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2020.102252_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.toxlet.2009.10.012","article-title":"Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in hepg2 cells by xrcc1 abrogation related mechanisms","volume":"192","author":"Zhang","year":"2010","journal-title":"Toxicol Lett"},{"issue":"5","key":"10.1016\/j.nano.2020.102252_bb0030","first-page":"955","article-title":"Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (review)","volume":"12","author":"Wang","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nano.2020.102252_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/08880010590964381","article-title":"Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine","volume":"22","author":"Sastry","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.nano.2020.102252_bb0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0378-5955(99)00190-2","article-title":"Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig","volume":"140","author":"Ekborn","year":"2000","journal-title":"Hear Res"},{"key":"10.1016\/j.nano.2020.102252_bb0045","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.0.CO;2-9","article-title":"Platinum organ toxicity and possible prevention in patients with testicular cancer","volume":"83","author":"Hartmann","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nano.2020.102252_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jinorgbio.2011.10.012","article-title":"Pt(IV) complexes as prodrugs for cisplatin","volume":"107","author":"Shi","year":"2012","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.nano.2020.102252_bb0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/med.21360","article-title":"Recent advances in platinum(IV) complex-based delivery systems to improve platinum (II) anticancer therapy","volume":"35","author":"Han","year":"2015","journal-title":"Med Res Rev"},{"key":"10.1016\/j.nano.2020.102252_bb0060","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1016\/j.biomaterials.2012.08.015","article-title":"The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy","volume":"33","author":"Xiao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2020.102252_bb0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00775-003-0471-6","article-title":"The cellular distribution and oxidation state of platinum(ii) and platinum(IV) antitumour complexes in cancer cells","volume":"8","author":"Hall","year":"2003","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.nano.2020.102252_bb0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1071\/CH9950793","article-title":"The influence of the axial ligands of a series of platinum(IV) anticancer complexes on their reduction to platinum(II) and reaction with DNA","volume":"48","author":"Ellis","year":"1995","journal-title":"Australian Journal of Chemistry"},{"key":"10.1016\/j.nano.2020.102252_bb0075","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1021\/ic951548n","article-title":"Studies on the oral anticancer drug jm-216: synthesis and characterization of isomers and related complexes","volume":"35","author":"Barnard","year":"1996","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nano.2020.102252_bb0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s002800050464","article-title":"Biotransformation of the platinum drug jm216 following oral administration to cancer patients","volume":"38","author":"Raynaud","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.nano.2020.102252_bb0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00775-014-1214-6","article-title":"Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application","volume":"20","author":"Theiner","year":"2015","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.nano.2020.102252_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s002800050941","article-title":"Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model","volume":"44","author":"Luo","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.nano.2020.102252_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd1088","article-title":"The dawning era of polymer therapeutics","volume":"2","author":"Duncan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2020.102252_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tibtech.2005.11.006","article-title":"Polymer conjugates: nanosized medicines for treating cancer","volume":"24","author":"Vicent","year":"2006","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2020.102252_bb0105","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/j.biomaterials.2012.06.071","article-title":"A poly(\u03b3, l-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery","volume":"33","author":"Xiong","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2020.102252_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejps.2018.04.022","article-title":"Cisplatin-stitched \u03b1-poly(glutamatic acid) nanoconjugate for enhanced safety and effective tumor inhibition","volume":"119","author":"Wang","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2020.102252_bb0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2020.102252_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0960-8524(01)00074-8","article-title":"The production of poly-(gamma-glutamic acid) from microorganisms and its various applications","volume":"79","author":"Shih","year":"2001","journal-title":"Bioresour Technol"},{"key":"10.1016\/j.nano.2020.102252_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00306378","article-title":"Biosynthesis and chemical modification of poly(gamma-glutamic acid)","volume":"32","author":"Borbely","year":"1994","journal-title":"Polymer Bulletin"},{"key":"10.1016\/j.nano.2020.102252_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis \u2014 flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled Annexin-v","volume":"184","author":"Vermes","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nano.2020.102252_bb0135","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/10717544.2016.1225853","article-title":"Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency","volume":"24","author":"Wang","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2020.102252_bb0140","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1039\/C5TB01496D","article-title":"A dextran\u2013platinum(IV) conjugate as a reduction-responsive carrier for triggered drug release","volume":"3","author":"He","year":"2015","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2020.102252_bb0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2017.04.002","article-title":"Reactive oxygen species activated nanoparticles with tumor acidity internalization for precise anticancer therapy","volume":"255","author":"Deng","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2020.102252_bb0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2013.01.023","article-title":"Clarithromycin-loaded liposomes offering high drug loading and less irritation","volume":"443","author":"Liu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2020.102252_bb0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00280-006-0366-7","article-title":"Comparative nephrotoxicity of cisplatin and new octahedral pt(IV) complexes","volume":"60","author":"Kim","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.nano.2020.102252_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.06.013","article-title":"Exploiting passive nanomedicine accumulation at sites of enhanced vascular permeability for non-cancerous applications","volume":"261","author":"Durymanov","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2020.102252_bb0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2020.102252_bb0170","first-page":"307","article-title":"Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels","volume":"62","author":"Kuppusamy","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2020.102252_bb0175","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","article-title":"Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple","volume":"30","author":"Schafer","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nano.2020.102252_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2011.01.030","article-title":"Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery","volume":"152","author":"Cheng","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2020.102252_bb0185","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1039\/C4PY01592D","article-title":"Tumor-targeting delivery of hyaluronic acid-platinum(IV) nanoconjugate to reduce toxicity and improve survival","volume":"6","author":"Ling","year":"2015","journal-title":"Polymer Chemistry"},{"key":"10.1016\/j.nano.2020.102252_bb0190","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1016\/j.biomaterials.2011.06.072","article-title":"Biodegradable polymer\u2013cisplatin(IV) conjugate as a pro-drug of cisplatin(II)","volume":"32","author":"Xiao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2020.102252_bb0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejps.2018.04.022","article-title":"Cisplatin-stitched \u03b1-poly(glutamatic acid) nanoconjugate for enhanced safety and effective tumor inhibition","volume":"119","author":"Wang","year":"2018","journal-title":"Eur J Pharm Sci"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:15:08Z","timestamp":1761549308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963420301064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":39,"alternative-id":["S1549963420301064"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2020.102252","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox-sensitive polyglutamic acid-platinum(IV) prodrug grafted nanoconjugates for efficient delivery of cisplatin into breast tumor","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2020.102252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102252"}}